327 related articles for article (PubMed ID: 9877080)
1. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
[TBL] [Abstract][Full Text] [Related]
2. The ursodeoxycholate dose-dependent formation of ursodeoxycholate-glucuronide in the rat and the choleretic potencies.
Takikawa H; Sano N; Narita T; Yamanaka M
Hepatology; 1990 May; 11(5):743-9. PubMed ID: 2347548
[TBL] [Abstract][Full Text] [Related]
3. Hepatic biotransformation and choleretic effect of 7-ketolithocholic acid in the rat.
Kanai S; Sato Y; Nokubo M; Kitani K
Lipids; 1989 Oct; 24(10):859-65. PubMed ID: 2811609
[TBL] [Abstract][Full Text] [Related]
4. Bile secretory characteristics of beta-muricholate and its taurine conjugate are similar to those of ursodeoxycholate in the rat.
Kanai S; Kitani K; Sato Y
Life Sci; 1991; 48(10):949-57. PubMed ID: 2000026
[TBL] [Abstract][Full Text] [Related]
5. Effects of ursodeoxycholate, its glucuronide and disulfate and beta-muricholate on biliary bicarbonate concentration and biliary lipid excretion.
Takikawa H; Sano N; Minagawa K; Yamanaka M
J Hepatol; 1992 May; 15(1-2):77-84. PubMed ID: 1506660
[TBL] [Abstract][Full Text] [Related]
6. The bile flow and biliary excretion of ursocholate in the rat.
Kitani K; Kanai S; Sato Y; Uchida K
Life Sci; 1983 Dec; 33(24):2377-86. PubMed ID: 6645805
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.
Setchell KD; Rodrigues CM; Podda M; Crosignani A
Gut; 1996 Mar; 38(3):439-46. PubMed ID: 8675100
[TBL] [Abstract][Full Text] [Related]
8. Biliary excretion of tauroursodeoxycholate-3-sulfate in the rat.
Akimoto K; Sano N; Takikawa H
Steroids; 2001 Sep; 66(9):701-5. PubMed ID: 11546558
[TBL] [Abstract][Full Text] [Related]
9. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
Sano N; Takikawa H; Yamanaka M
J Hepatol; 1993 Feb; 17(2):241-6. PubMed ID: 8445238
[TBL] [Abstract][Full Text] [Related]
10. Role of H+ transport in ursodeoxycholate-induced biliary HCO-3 secretion in the rat.
Garcia-Marin JJ; Corbic M; Dumont M; de Couët G; Erlinger S
Am J Physiol; 1985 Sep; 249(3 Pt 1):G335-41. PubMed ID: 2994491
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of bile acid N-acetylglucosaminides in serum and urine of patients with chronic liver diseases during ursodeoxycholic acid treatment].
Kimura A; Nakamura K; Makino I
Nihon Shokakibyo Gakkai Zasshi; 1995 Mar; 92(3):224-32. PubMed ID: 7731091
[TBL] [Abstract][Full Text] [Related]
12. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.
Yoon YB; Hagey LR; Hofmann AF; Gurantz D; Michelotti EL; Steinbach JH
Gastroenterology; 1986 Apr; 90(4):837-52. PubMed ID: 3949115
[TBL] [Abstract][Full Text] [Related]
13. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.
Invernizzi P; Setchell KD; Crosignani A; Battezzati PM; Larghi A; O'Connell NC; Podda M
Hepatology; 1999 Feb; 29(2):320-7. PubMed ID: 9918905
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of ursodeoxycholate and its taurine conjugate on biliary transport maximum of bilirubin in the rat.
Sánchez Pozzi EJ; Mottino AD; Sisti A; Roma MG
Life Sci; 1995; 57(10):973-81. PubMed ID: 7643722
[TBL] [Abstract][Full Text] [Related]
15. Influence of backward perfusion on ursodeoxycholate-induced choleresis in isolated in situ rat liver.
Perez Barriocanal F; Marin JJ; Dumont M; Erlinger S
J Hepatol; 1990 Sep; 11(2):165-71. PubMed ID: 2254627
[TBL] [Abstract][Full Text] [Related]
16. Effect of systemic pH, PCO2 and bicarbonate concentration on biliary bicarbonate secretion in the rat.
Corbic M; Muñoz C; Dumont M; de Couët G; Erlinger S
Hepatology; 1985; 5(4):594-9. PubMed ID: 3926617
[TBL] [Abstract][Full Text] [Related]
17. Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat.
Angelico M; Baiocchi L; Nistri A; Franchitto A; Della Guardia P; Gaudio E
Dig Dis Sci; 1994 Nov; 39(11):2389-97. PubMed ID: 7956608
[TBL] [Abstract][Full Text] [Related]
18. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.
Heuman DM; Mills AS; McCall J; Hylemon PB; Pandak WM; Vlahcevic ZR
Gastroenterology; 1991 Jan; 100(1):203-11. PubMed ID: 1983822
[TBL] [Abstract][Full Text] [Related]
19. Hypercholeresis induced by unconjugated bile acid infusion correlates with recovery in bile of unconjugated bile acids.
Gurantz D; Schteingart CD; Hagey LR; Steinbach JH; Grotmol T; Hofmann AF
Hepatology; 1991 Mar; 13(3):540-50. PubMed ID: 1999323
[TBL] [Abstract][Full Text] [Related]
20. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
Piazza F; Montagnani M; Russo C; Azzaroli F; Aldini R; Roda E; Roda A
Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
